XT
IMCR icon

XTX Topco’s Immunocore IMCR Stock Holding History

XTX Topco’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Buy
96,106
+74,115
+337% +$2.4M 0.05% 580
2025
Q4 		$763K Buy
+21,991
New +$776K 0.02% 1237
2025
Q3 		– Sell
-20,873
Closed -$655K – 2874
2025
Q2 		$655K Buy
20,873
+2,681
+15% +$83.3K 0.03% 926
2025
Q1 		$540K Sell
18,192
-704
-4% -$21.1K 0.03% 977
2024
Q4 		$557K Buy
18,896
+3,437
+22% +$109K 0.05% 681
2024
Q3 		$481K Buy
15,459
+6,516
+73% +$237K 0.03% 844
2024
Q2 		$303K Buy
+8,943
New +$456K 0.03% 956

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

XTX Topco's IMCR Position: Q1 2026 in Review

XTX Topco increased its Immunocore (IMCR) stake by 337% in Q1 2026, buying an estimated $2.4M and bringing the position to 96,106 shares worth $2.9M. The position accounts for 0.05% of the portfolio, ranked #580.

XTX Topco first reported a position in IMCR in Q2 2024 and has held it in 7 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • XTX Topco held 96,106 shares of Immunocore worth $2.9M as of Q1 2026.
  • XTX Topco bought 74,115 Immunocore shares in Q1 2026, an estimated $2.4M.
  • Immunocore made up 0.05% of XTX Topco's portfolio in Q1 2026, its #580 holding.
  • XTX Topco first reported a position in Immunocore in Q2 2024 and has held it in 7 quarters since.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.